155 related articles for article (PubMed ID: 29343884)
1. Neutral Sphingomyelinase Behaviour in Hippocampus Neuroinflammation of MPTP-Induced Mouse Model of Parkinson's Disease and in Embryonic Hippocampal Cells.
Cataldi S; Arcuri C; Hunot S; Légeron FP; Mecca C; Garcia-Gil M; Lazzarini A; Codini M; Beccari T; Tasegian A; Fioretti B; Traina G; Ambesi-Impiombato FS; Curcio F; Albi E
Mediators Inflamm; 2017; 2017():2470950. PubMed ID: 29343884
[TBL] [Abstract][Full Text] [Related]
2. Neutral sphingomyelinase increases and delocalizes in the absence of Toll-Like Receptor 4: A new insight for MPTP neurotoxicity.
Albi E; Cataldi S; Codini M; Mariucci G; Lazzarini A; Ceccarini MR; Ferri I; Laurenti ME; Arcuri C; Patria F; Beccari T; Conte C
Prostaglandins Other Lipid Mediat; 2019 Jun; 142():46-52. PubMed ID: 30928412
[TBL] [Abstract][Full Text] [Related]
3. [Effect of phosphorylated-ERK1/2 on inducible nitric oxide synthase expression in the substantia nigra of mice with MPTP-induced Parkinson disease].
Shi C; Zhang YX; Zhang ZF
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):60-3. PubMed ID: 19218114
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases.
López A; Ortiz F; Doerrier C; Venegas C; Fernández-Ortiz M; Aranda P; Díaz-Casado ME; Fernández-Gil B; Barriocanal-Casado E; Escames G; López LC; Acuña-Castroviejo D
PLoS One; 2017; 12(8):e0183090. PubMed ID: 28800639
[TBL] [Abstract][Full Text] [Related]
5. Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation.
Okazaki T; Bell RM; Hannun YA
J Biol Chem; 1989 Nov; 264(32):19076-80. PubMed ID: 2808413
[TBL] [Abstract][Full Text] [Related]
6. Physical exercise counteracts MPTP-induced changes in neural precursor cell proliferation in the hippocampus and restores spatial learning but not memory performance in the water maze.
Klein C; Rasińska J; Empl L; Sparenberg M; Poshtiban A; Hain EG; Iggena D; Rivalan M; Winter Y; Steiner B
Behav Brain Res; 2016 Jul; 307():227-38. PubMed ID: 27012392
[TBL] [Abstract][Full Text] [Related]
7. Rolipram improves facilitation of contextual fear extinction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Kinoshita KI; Muroi Y; Unno T; Ishii T
J Pharmacol Sci; 2017 May; 134(1):55-58. PubMed ID: 28456375
[TBL] [Abstract][Full Text] [Related]
8. Endurance exercise training protects against the upregulation of nitric oxide in the striatum of MPTP/probenecid mouse model of Parkinson's disease.
Al-Jarrah M; Obaidat H; Bataineh Z; Walton L; Al-Khateeb A
NeuroRehabilitation; 2013; 32(1):141-7. PubMed ID: 23422467
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson's disease by targeting Nlrp3.
Li D; Yang H; Ma J; Luo S; Chen S; Gu Q
Hum Cell; 2018 Apr; 31(2):106-115. PubMed ID: 29274035
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of neutral sphingomyelinase decreases elevated levels of inducible nitric oxide synthase and apoptotic cell death in ocular hypertensive rats.
Aslan M; Basaranlar G; Unal M; Ciftcioglu A; Derin N; Mutus B
Toxicol Appl Pharmacol; 2014 Nov; 280(3):389-98. PubMed ID: 25201535
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of inducible nitric oxide synthase expression and cell death by (-)-epigallocatechin-3-gallate, a green tea catechin, in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
Kim JS; Kim JM; O JJ; Jeon BS
J Clin Neurosci; 2010 Sep; 17(9):1165-8. PubMed ID: 20541420
[TBL] [Abstract][Full Text] [Related]
12. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease.
Liberatore GT; Jackson-Lewis V; Vukosavic S; Mandir AS; Vila M; McAuliffe WG; Dawson VL; Dawson TM; Przedborski S
Nat Med; 1999 Dec; 5(12):1403-9. PubMed ID: 10581083
[TBL] [Abstract][Full Text] [Related]
13. Acorus gramineus inhibits microglia mediated neuroinflammation and prevents neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease.
Jiang J; Kim JJ; Kim DY; Kim MK; Oh NH; Koppula S; Park PJ; Choi DK; Shin YK; Kim IH; Kang TB; Lee KH
J Ethnopharmacol; 2012 Dec; 144(3):506-13. PubMed ID: 23085397
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of the andrographolide analogue AL-1 in the MPP⁺/MPTP-induced Parkinson's disease model in vitro and in mice.
Zhang Z; Lai D; Wang L; Yu P; Zhu L; Guo B; Xu L; Zhou L; Sun Y; Lee SM; Wang Y
Pharmacol Biochem Behav; 2014 Jul; 122():191-202. PubMed ID: 24726706
[TBL] [Abstract][Full Text] [Related]
15. Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease.
Chung YC; Kim SR; Jin BK
J Immunol; 2010 Jul; 185(2):1230-7. PubMed ID: 20566832
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells.
Yeo S; Sung B; Hong YM; van den Noort M; Bosch P; Lee SH; Song J; Park SK; Lim S
Gene; 2018 Jun; 661():189-195. PubMed ID: 29604467
[TBL] [Abstract][Full Text] [Related]
17. Neutral sphingomyelinase inhibition decreases ER stress-mediated apoptosis and inducible nitric oxide synthase in retinal pigment epithelial cells.
Kucuksayan E; Konuk EK; Demir N; Mutus B; Aslan M
Free Radic Biol Med; 2014 Jul; 72():113-23. PubMed ID: 24742815
[TBL] [Abstract][Full Text] [Related]
18. Nuclear sphingomyelin pathway in serum deprivation-induced apoptosis of embryonic hippocampal cells.
Albi E; Cataldi S; Bartoccini E; Magni MV; Marini F; Mazzoni F; Rainaldi G; Evangelista M; Garcia-Gil M
J Cell Physiol; 2006 Jan; 206(1):189-95. PubMed ID: 16021626
[TBL] [Abstract][Full Text] [Related]
19. Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Joniec I; Ciesielska A; Kurkowska-Jastrzebska I; Przybylkowski A; Czlonkowska A; Czlonkowski A
Brain Res; 2009 Mar; 1261():7-19. PubMed ID: 19401171
[TBL] [Abstract][Full Text] [Related]
20. Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-κB Pathway.
Jing H; Wang S; Wang M; Fu W; Zhang C; Xu D
PLoS One; 2017; 12(1):e0169560. PubMed ID: 28060896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
